Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer.
Gedik ME, Saatci O, Oberholtzer N, Uner M, Akbulut O, Cetin M, Aras M, Ibis K, Caliskan B, Banoglu E, Wiemann S, Uner A, Aksoy S, Mehrotra S, Sahin O.
Gedik ME, et al. Among authors: wiemann s.
bioRxiv [Preprint]. 2023 Sep 14:2023.09.12.557273. doi: 10.1101/2023.09.12.557273.
bioRxiv. 2023.
PMID: 37745348
Free PMC article.
Updated.
Preprint.